U-Haul International prepares to report its fourth-quarter financial results amid a mixed landscape for transportation and logistics firms. Investors are watching for signs of a rebound after recent profit misses.
The adhesive and materials giant is expected to post modest revenue growth as investors gauge its resilience against a backdrop of uneven results from packaging industry peers.
Bio-Techne prepares to report quarterly earnings against a backdrop of declining revenue projections and mixed performances from life sciences peers.
CDW Corporation is set to report its fourth-quarter earnings before the market opens on Wednesday. Analysts project modest revenue growth, but the company's recent performance and broader sector trends suggest a cautious outlook.
Healthcare distribution giant Cencora (COR) is set to report quarterly earnings before Wednesday's market open. Analysts project steady revenue growth, but investor focus will be on guidance amid mixed performances from sector peers.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
ASGN Inc. is set to report its fourth-quarter financial results after the bell on Wednesday, with Wall Street anticipating another year-over-year revenue decline. Investors will scrutinize the performance for signs of stabilization in a competitive sector.
Global equities and commodities staged a broad recovery on Tuesday, shaking off a pan-Asian rout triggered by a hawkish Fed nominee and geopolitical jitters. The rebound was anchored by surprisingly strong US manufacturing figures, offering a respite to bruised investors.
A Los Angeles family is mourning the devastating loss of Regan Cole-Graham, 36, and her unborn daughter after a cycling accident. The mother of two was riding with her family when she was struck by a vehicle.
A sophisticated, high-conviction options trade by a large investor signals strong confidence in Edwards Lifesciences' fundamentals, with a potential breakout eyed for early 2026 tied to regulatory milestones and sustained growth in its mitral valve business.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
A year after Hanoi and Washington elevated ties to a Comprehensive Strategic Partnership, an internal Vietnamese military document reveals deep-seated fears of U.S. aggression and 'color revolutions,' highlighting the complex duality at the heart of Vietnam's foreign policy.
Elon Musk's SpaceX is set to acquire his artificial intelligence startup xAI in a landmark share exchange, with investors offered 0.1433 SpaceX shares for each xAI share, according to a source familiar with the transaction. The deal underscores Musk's strategy of consolidating his tech empire amid fierce AI competition.
As hyperscalers like Amazon prepare to report earnings, the focus is shifting from quarterly sales to massive capital investments in AI infrastructure and strategic partnerships with GPU-as-a-service providers.
As Ford Motor Company takes a massive charge on its electric vehicle business, a bullish investment thesis is gaining traction, arguing the automaker's strategic shift toward hybrids and profitable segments could unlock long-term value.
Aerospace and defense systems leader Woodward (NASDAQ:WWD) posted fourth-quarter results that handily exceeded Wall Street forecasts, sending its stock sharply higher. Revenue jumped 29% year-over-year to $996.5 million, while earnings per share of $2.17 beat consensus estimates by nearly 30%.
Former President Bill Clinton and former Secretary of State Hillary Clinton have reversed course and agreed to provide testimony to the House Oversight Committee's investigation into Jeffrey Epstein, following the panel's move to hold them in contempt.
State Rep. James Talarico pushes back against claims he called former Congressman Colin Allred a 'mediocre Black man,' attributing the dispute to a misinterpreted private conversation as a heated Democratic primary intensifies.
Shares of the electronic brokerage firm edged higher after reporting strong monthly performance figures, fueled by a sustained rally in U.S. securities trading and significant growth in client activity.
As the 2026 election cycle approaches, Gray Media emerges as a contrarian play. Analysts point to its potential for a significant re-rating, driven by political advertising cyclicality, stable retransmission fees, and a trove of undervalued hard assets.
